Sanofi am morgen >2% im Plus aufgrund überzeugender Q1-Zahlen.
Sanofi (NASDAQ:SNY): Q1 Non-GAAP EPS of €1.42 beats by €0.10;
Revenue of €8.39B (+6.2% Y/Y)
https://www.sanofi.com/en/investors/fina...sults-2019
Sanofi (NASDAQ:SNY): Q1 Non-GAAP EPS of €1.42 beats by €0.10;
Revenue of €8.39B (+6.2% Y/Y)
https://www.sanofi.com/en/investors/fina...sults-2019